A Collaborative Initiative For the Containment of Antimicrobial Resistance in Mexico

Antimicrobial resistance exacts worldwide an increasingly significant clinical and economic toll. Despite the international calls for urgent action, antimicrobial use and resistance have been low on the Mexican government's policy agenda. In early 2010, a multidisciplinary group of experts launched a national initiative for containment of antimicrobial resistance that was endorsed by major medical, veterinary and public health institutions. The initiative called for seven priority actions including the creation of an ad hoc intersectoral advisory group, a requirement that human and veterinary antibiotics be dispensed only with prescription, and the establishment of effective surveillance systems. A consensus document was disseminated among key decision‐makers at the ministries of Health and Agriculture and the legislature. The Ministry of Health (MoH) enacted a decree effective as of August 2010, which enforced the regulations that required medical prescriptions for the sale of human antibiotics. While the information disseminated by the MoH did focus on the dangers of self‐medication, it failed to highlight the inherent perils of antibiotic resistance or the consequences of antibiotic use in food‐animals. Following the decree, there was a surge of medical offices controlled by retail pharmacies. In the veterinary sector, voluntary guidelines were developed for good husbandry practices, including antibiotic use in food animals; five antimicrobials for use in food‐animals were banned. No intersectoral advisory group or surveillance systems were established. This study describes a bottom‐top approach in Mexico for the development of a national strategy to improve antibiotic use and contain antimicrobial resistance. Its experiences suggest that, in countries such as Mexico that lack strong regulatory systems and surveillance capacities, a more systemic approach is warranted. Future efforts should begin with early involvement of key stakeholders and informing policy makers, professionals and the population at large about the critical importance of antibiotic resistance.

[1]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[2]  H. Leufkens,et al.  Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico , 2013, PloS one.

[3]  Richard Smith,et al.  The true cost of antimicrobial resistance , 2013, BMJ.

[4]  V. Wirtz,et al.  Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation , 2012, BMC Public Health.

[5]  N. Homedes,et al.  Mexican Pharmacies and Antibiotic Consumption at the US-Mexico Border , 2012, Southern med review.

[6]  P. McDermott,et al.  Antimicrobial-resistant Campylobacter in the food chain in Mexico. , 2012, Foodborne pathogens and disease.

[7]  H. Sader,et al.  Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005–2010 , 2012, BMC Research Notes.

[8]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[9]  R. Gonzales,et al.  Trends in antibiotic utilization in eight Latin American countries, 1997-2007. , 2010, Revista panamericana de salud publica = Pan American journal of public health.

[10]  F. P. De la Hoz,et al.  Laboratory-Based Surveillance of Streptococcus pneumoniae Invasive Disease in Children in 10 Latin American Countries: A SIREVA II Project, 2000–2005 , 2009, The Pediatric infectious disease journal.

[11]  S. Cosgrove,et al.  Clinical and economic burden of antimicrobial resistance , 2008, Expert review of anti-infective therapy.

[12]  G. Echániz,et al.  Uso de antibióticos en México: revisión de problemas y políticas , 2008 .

[13]  Shaohua Zhao,et al.  Integrated Food Chain Surveillance System for Salmonella spp. in Mexico , 2008, Emerging infectious diseases.

[14]  P. McDermott,et al.  Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico. , 2007, The Journal of antimicrobial chemotherapy.

[15]  G. Midgley Systemic intervention for public health. , 2006, American journal of public health.

[16]  J. Calva,et al.  Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. , 2002, Archives of medical research.

[17]  Alison Mack,et al.  Improving food safety through a one health approach: workshop summary. , 2012 .

[18]  Satya Sivaraman,et al.  News Media Reporting of Antimicrobial Resistance in Latin America and India , 2010 .

[19]  G. Echániz,et al.  [Antibiotic use in Mexico: review of problems and policies]. , 2008, Salud publica de Mexico.